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Though synesthesia research has seen a huge growth in recent decades, and tremendous
progress has been made in terms of understanding the mechanism and cause of
synesthesia, we are still left mostly in the dark when it comes to the mechanistic
commonalities (if any) among developmental, acquired and drug-induced synesthesia.
We know that many forms of synesthesia involve aberrant structural or functional brain
connectivity. Proposed mechanisms include direct projection and disinhibited feedback
mechanisms, in which information from two otherwise structurally or functionally separate
brain regions mix. We also know that synesthesia sometimes runs in families. However,
it is unclear what causes its onset. Studies of psychedelic drugs, such as psilocybin,
LSD and mescaline, reveal that exposure to these drugs can induce synesthesia. One
neurotransmitter suspected to be central to the perceptual changes is serotonin. Excessive
serotonin in the brain may cause many of the characteristics of psychedelic intoxication.
Excessive serotonin levels may also play a role in synesthesia acquired after brain injury. In
brain injury sudden cell death ﬂoods local brain regions with serotonin and glutamate.
This neurotransmitter ﬂooding could perhaps result in unusual feature binding. Finally,
developmental synesthesia that occurs in individuals with autism may be a result of
alterations in the serotonergic system, leading to a blockage of regular gating mechanisms.
I conclude on these grounds that one commonality among at least some cases of acquired,
developmental and drug-induced synesthesia may be the presence of excessive levels of
serotonin, which increases the excitability and connectedness of sensory brain regions.
Keywords: acquired synesthesia, autism spectrum disorder, drug-induced synaesthesia, left-hemisphere injuries,
multisensory perception, savant syndrome, serotonin hypothesis, traumatic brain injury
INTRODUCTION
Synesthesia is an extraordinary way of perceiving the world,
involving experiences of connections between seemingly unre-
lated sensations, images or thoughts (Baron-Cohen et al., 1987;
Cytowic, 1989; Rich and Mattingley, 2002; Sagiv and Ward, 2006;
Brogaard, 2012). For example, seeing the number 7 may lead to
an experience of navy blue, hearing the word “bliss” may ﬂood
the mouth with the ﬂavor of bread soaked in tomato soup and
hearing the key of C# minor may elicit a bright purple spiral
radiating from the center of the visual ﬁeld. The trigger of the
experience is called “the inducer,” whereas the additional experi-
ence towhich it gives rise is called“the concurrent”(Grossenbacher
and Lovelace, 2001). In visual synesthesia, the concurrent may be
projected out into space and experienced as located in the visual
scene outside the subject’s mind, or it may be merely imagis-
tically or semantically associated with the inducer (Dixon et al.,
2004).
The two key characteristics of synesthesia regardless of whether
it is of the projector or associator type is that it involves an aberrant
binding of features fromdifferent sensory or cognitive streams that
are associated with atypical conscious experiences or thoughts and
that these experiences or thoughts are automatic, that is, synes-
thetes cannot suppress the association between an inducer and
its concurrent. Other characteristics of the condition are speciﬁc
to the different forms. According to Grossenbacher and Lovelace
(2001), there are three different types of synesthesia:
(1) Developmental, or genuine, synesthesia
(2) Acquired synesthesia
(3) Drug-induced synesthesia
Developmental synesthesia, the most common type, is a form
of the condition that has persisted since birth or early childhood
and that remains relatively stable and systematic over time: each
inducer has a highly speciﬁc concurrent. (Baron-Cohen et al.,
1987; Mattingley et al., 2001; Simner et al., 2006). It also tends
to run in families (Baron-Cohen et al., 1996). For the most com-
mon forms of developmental synesthesia, the Synesthesia Battery,
an automated online test, allows for rigorous testing of both
the tightness of the synesthetic association and its stability and
systematicity over time (www.synaesthete.org; Eagleman et al.,
2007).
Acquired synesthesia is a form of the condition that emerges
after brain injury or disease or artiﬁcial technologies like sen-
sory substitution (Ward and Wright, 2012). It has been reported
following stroke (Ro et al., 2007; Beauchamp and Ro, 2008;
Thomas-Anterion et al., 2010; Schott, 2012), traumatic brain
injury (Brogaard et al., 2012; Brogaard and Marlow, 2013), neu-
ropathology involving the optic nerve and/or chiasm (Jacobs et al.,
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1981; Armel and Ramachandran, 1999; Afra et al., 2009), seizures
(Jacome and Gumnit, 1979), migraine (Alstadhaug and Ben-
jaminsen, 2010), post-hypnotic suggestion (Cohen Kadosh et al.,
2009) and sensory substitution (Ward and Wright, 2012). Audio-
visual synesthesia has been reported to be the most common
acquired type (Afra et al., 2009). Like developmental synesthe-
sia, acquired synesthesia tends to be automatic and systematic
over time, though in some cases it only persists for a limited
time period (Jacome and Gumnit, 1979; Lessell and Cohen,
1979; Afra et al., 2009). Experientally, acquired synesthesia may
be indistinguishable from developmental synesthesia, though it
is sometimes less inducer-speciﬁc, that is, the same concur-
rent may have several different inducers (Brogaard et al., 2012).
Cases have also been reported in which the acquired experience
is simpler than the developmental counterpart, often similar to
light ﬂashes (phosphenes) or pure color experiences (Afra et al.,
2009).
Drug-induced synesthesia is a blending of sensory or cogni-
tive streams that is experienced during exposure to a hallucinogen
(psilocybin, LSD, mescaline, peyote; Shanon, 2002; Friedrichs,
2009; Sinke et al., 2012). Unlike the developmental and acquired
varieties, the drug-induced form is usually limited to the most
intense phases of intoxication, though in some cases it continues
for weeks or months after exposure to the drug (Abraham, 1983;
Ffytche, 2007). Experientally, drug-induced synesthesia can vary
from simple color experiences to complex, surrealistic landscapes
consisting of, for example, oddly shaped objects with multi-
colored contours or images with ornamental or kaleidoscopic
compositions (Hintzen and Passie, 2010).
Though synesthesia research has seen a huge growth in
recent decades, and tremendous progress has been made in
terms of understanding the mechanism and cause of the con-
dition, we are still left mostly in the dark when it comes to
the mechanistic commonalities (if any) among developmental,
acquired and drug-induced synesthesia. It is widely believed
that most forms of the condition involve functional or struc-
tural aberrant brain connectivity. The proposed mechanisms
include direct or indirect projection through increased struc-
tural connectivity (Ramachandran and Hubbard, 2001a,b; Hub-
bard et al., 2005; Rouw and Scholte, 2007; Jancke et al., 2009;
Hanggi et al., 2011; Zamm et al., 2013), functionally driven
disinhibited-feedback mechanisms (Grossenbacher and Lovelace,
2001; Dixon et al., 2006; Esterman et al., 2006; Neufeld et al.,
2012), and mixed models (Hubbard, 2007; Ward, 2013). How-
ever, it is unclear what causes the onset of the condition
and whether the different types of synesthesia have different
causes.
One proposal by Brang and Ramachandran (2007) suggests
serotonin (5-HT) as a causal factor. Their speciﬁc suggestion is
that “serotonin S2a receptors are the ‘synesthesia receptors’ in
the brain” (p. 903). In support of this hypothesis they list four
pieces of evidence: (i) LSD produces synesthesia by selectively
activating serotonin 5-HT2A receptors. (ii) Prozac (ﬂuoxetine), a
selective serotonin reuptake inhibitor that increases 5-HT1 recep-
tor activity thereby inhibiting 5-HT2A, blocked synesthesia in
two subjects. (iii) the anxiolytic drug Wellbutrin (bupropion),
which presumably inhibits 5-HT2A receptor activity, temporarily
abolished synesthesia in one subject, (iv) melatonin, a brain hor-
mone derived from serotonin that can disinhibit 5-HT2A receptor
activity, temporarily induced grapheme-color synesthesia in a
subject with number-form synesthesia.
Thus, Brang and Ramachandran’s (2007) suggestion is that
serotoninmay be functionally implicated in generating synesthetic
experience through 5-HT2A receptor activity. In the formulation
of the hypothesis Brang and Ramachandran (2007) do not spec-
ify which of the 5-HT2A receptors in the brain cause synesthesia,
whether the serotonin receptors that are“synesthesia receptors”are
inhibitory or excitatory, whether serotonin could be structurally
implicated in causing synesthesia through altered structural con-
nectivity during brain development and whether the serotonin
hypothesis may also explain cases of acquired synesthesia. My
aim in this paper is to develop the serotonin hypothesis to ten-
tatively answer these questions by looking at a wider range of
evidence.
More speciﬁcally, my proposal is that excessive extracellular
serotonin (5-HT) can be a trigger of persistent or transient synes-
thesia in all the groups through excitatory mechanisms. Though
serotonin traditionally has been considered an inhibitory neuro-
transmitter,more recent evidence suggests amore complex picture
according to which serotonin can function both as an inhibitory
and an excitatory neurotransmitter. For example, serotonin helps
reduce fear processing in the amygdala via GABA modulation but
it exerts an excitatory effect on cortical brain activity when it binds
to 5-HT2A serotonin receptors on layer V pyramidal neurons
(Barkai and Hasselmo, 1994; Aghajanian and Marek, 1999).
As indicated by Brang and Ramachandran (2007), the sug-
gestion that serotonergic activity may be a trigger of synesthesia
has the greatest degree of evidential backing in the case of drug-
induced synesthesia. It has been shown in several studies that
psychedelic hallucinogens that function primarily as serotonin
agonists, such as psilocybin, LSD and mescaline, often induce
transient, often auditory-visual synesthesia, presumably through
an alteration of functional brain connectivity. Though not all sero-
tonin agonists elicit synesthetic experience, it is widely agreed that
the mechanism of action for the class of serotonergic hallucino-
gens is through binding of serotonin to the 5-HT2A serotonin
receptor (Presti and Nichols, 2004; González-Maeso et al., 2007).
Excessive serotonin levels may also play a role in synesthe-
sia acquired after brain injury. Research has shown that necrosis
following tissue damage leads to local neurotransmitter ﬂooding
caused by an excessive release of serotonin and glutamate (Busto
et al., 1997; Hinzman et al., 2010), a phenomenon that can have
long-range consequences even when the injury is minor. This
ﬂooding appears to lead to increased functional or structural inter-
connectedness among different brain regions in some individuals,
and in some cases this increased connectivity may be a cause of
synesthesia.
Developmental synesthesia has been reported as a condition
in autism-spectrum disorders (Ornitz et al., 1978; Grandin, 1995;
Kemner et al., 1995; Harrison and Hare, 2004; Asher et al., 2009;
Baron-Cohen et al., 2009), and is believed to be more frequently
occurring in individuals with autism compared to the general pop-
ulation (Cytowic, 1989). It is suggested below that synesthesia
accompanying autism may be a serotonergic condition, resulting
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from excessive serotonin levels in early childhood that could pos-
sibly lead to decreased extracellular levels of serotonin in one
hemisphere and compensatory increased levels in the other hemi-
sphere. One piece of evidence for this comes from PET scans of
people with high-functioning autism which have revealed that in
the majority of cases serotonin synthesis is suppressed in the left
hemisphere and increased in the right hemisphere, though in some
cases it is reversed (Chandana et al., 2005). Recent genetic studies
furthermore suggest a genetic link between autism spectrum dis-
order and developmental synesthesia in non-autistic individuals
(Asher et al., 2009). Whether there is a mechanistic link between
autism and cases of developmental synesthesia in non-autistic
individuals remains to be established.
In what follows I will provide detailed evidence for the
hypothesis that one commonality among at least some cases
of acquired, developmental and drug-induced synesthesia is the
presence of excessive levels of serotonin or serotonin-agonists,
which increase the excitability and connectedness of sensory brain
regions through 5-HT2A receptors in cortical neurons.
ACQUIRED SYNESTHESIA
The acquired form of synesthesia usually emerges subsequent to
traumatic brain injury or neuropathologic insult to the brain
(Beauchamp and Ro, 2008; Afra et al., 2009; Brogaard et al., 2012).
Several studies have hypothesized that these acquired synesthesias
occur from plasticity of the sensory systems resulting in increased
connectivity (Ro et al., 2007; Beauchamp and Ro, 2008). This the-
ory has additionally been studied in at least one case of acquired
synesthesia (Ro et al., 2012). Ro et al. (2012) found that connec-
tions between the auditory and somatosensory cortices in healthy
controlswere strengthened in a subjectwith auditory-tactile synes-
thesia acquired after a right ventrolateral thalamic lesion that
deprived her somatosensory cortex of normal somatosensory
input.
It remains largely unknown how a brain lesion may give rise
to the plastic changes that lead to the increased connectivity.
One possibility is that it is caused by increased neurotrans-
mitter activity in cortical regions adjacent to the affected site.
This increase is believed to contribute to the pathophysiology
and neurological dysfunction after traumatic brain injury (Busto
et al., 1997; Bullock et al., 1998; Robertson et al., 2001; Werner
and Engelhard, 2007; Hinzman et al., 2010). In traumatic brain
injury tissue damage makes the cells shift to anaerobic glycoly-
sis, resulting in an accumulation of lactic acid. The anaerobic
metabolism cannot by itself maintain the energy levels, so ATP-
stores are depleted and the membrane ion-pumps, which depend
on ATP, fail. This leads to membrane degradation of vascular
and cellular structures and necrotic or programmed cell death
(apoptosis), resulting in excessive release of excitatory neuro-
transmitters, particularly serotonin and glutamate (Busto et al.,
1997; Hinzman et al., 2010). This excess in extracellular sero-
tonin and glutamate availability affects neurons and astrocytes
and results in over-stimulation of serotonin and glutamate recep-
tors. It is believed that this over-stimulation effect can happen
even in mild traumatic brain injury, as the release of neuro-
transmitters is vast even with minor lesions (Konrad et al., 2011;
Perez-Polo et al., 2013). Other types of brain injury that have been
reported to trigger synesthesia, such as stroke (Ro et al., 2007;
Beauchamp and Ro, 2008; Afra et al., 2009; Thomas-Anterion
et al., 2010; Schott, 2012), also cause neurotransmitter ﬂooding
after necrosis. It has been found, for example, that even a brief
ischemic stroke may trigger complex biochemical events that lead
to progressive apoptotic and necrotic neuronal cell death (Yuan,
2009).
The increased levels of serotonin and glutamate immediately
following brain injury do not normally stay elevated for very long
(Eysel et al.,1999). Eysel et al. (1999) induced1.5 to 2mmlesions in
the striate cortex of cats using surface photocoagulationor ibotenic
acid injections. Single cell measurements revealed that activity
was decreased at the border of the lesion and increased in a ring
around the lesion during the ﬁrst days to weeks following the
induction but it returned to normal after about a month (Eysel
et al., 1999). Despite the fact that serotonin does not seem to stay
elevated for more than one month following a brain lesion, there
is suggestive evidence that the temporary elevation may sufﬁce
for creating long-lasting functional, and possibly also structural,
changes (Giza and Prins, 2006; Konrad et al., 2011; Perez-Polo
et al., 2013). It has furthermore been reported that initial increases
in neurotransmitter levels following brain injury or disease may
be followed by down-regulation of receptors in ipsilateral brain
regions (Giza and Prins, 2006).
One hypothesis for how brain injury or disease may cause
synesthesia, then, is that the initially elevated neurotransmitter
levels down-regulate serotonin receptors in neural regions in the
ipsilateral hemisphere, leading to decreased serotonin levels. Indi-
viduals who acquire synesthesia also sometimes develop autistic
traits and savant-like abilities of the sort seen in 10 percent of autis-
tic individuals (Baron-Cohen et al., 2007; Treffert, 2009; Brang
and Ramachandran, 2011; Rogowska, 2011; Brogaard et al., 2012;
Schott, 2012; Ward, 2013). Emerging savant skills have also been
reported in many other cases of central nervous system injury or
disease later in life (Fay, 1987; Dorman, 1991; Miller et al., 1998,
2000; Lythgoe et al., 2005; Tammet, 2006; Treffert, 2006, 2009;
Snyder, 2009). As is known from studies of autistic savants, down-
regulation of the serotonergic system in one hemispheremay result
in an upregulation of the serotonergic system in contralateral
brain regions (DeLong, 1999; Takeuchi et al., 2012), which might
explain the development of savant skill and synesthesia follow-
ing brain injury (Treffert, 2009). A second hypothesis is that the
elevation in serotonin and glutamate levels in the days or weeks
after brain injury can trigger disinhibited feedback or a struc-
tural binding of features through serotonergic hyperactivity in
sensory neurons or neurons in parietal cortex involved in mental
imagery. The latter have been found to be plausible neural corre-
lates in at least one case of acquired synesthesia (Brogaard et al.,
2012).
The second hypothesis is more plausible than the ﬁrst when
synesthesia is acquired after brain injury. It would explain the
increased ipsilateral connectivity found in at least one case of
acquired synesthesia (Ro et al., 2012). It gains further support
from the fact that the onset of synesthesia following brain injury
has been reported to occur shortly after the injury rather than
months later, which indicates that it is the initial neurotrans-
mitter ﬂooding that causes the onset. Furthermore, if the ﬁrst
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hypothesis were correct, then the affected region would have to
be crucially implicated if the down-regulation triggers an upregu-
lation in other areas, an assumption that cannot be conﬁrmed at
the present time. The ﬁrst hypothesis may have a greater degree of
support for synesthesia acquired after frontotemporal dementia.
Cell death in frontotemporal dementia does not normally occur
via necrosis that leads to neurotransmitter ﬂooding. However, it
is well known that patients with this condition have deﬁcits in
serotonergic anddopaminergic signal-transmission. These deﬁcits
may account for some of the cognitive and behavioral impair-
ments of the disease. As prefrontal areas are known to exert
inhibitory control over other brain regions, decreased activity
in these neural regions could lead to a disinhibitory enhance-
ment of neural activity and connectivity in unaffected cortical
regions (DeLong, 1999; Treffert, 2009), which could also explain
why this type of dementia frequently is reported as a cause of
savant skills (Miller et al., 2000). Regardless of whether the synes-
thesia is acquired after brain injury or dementia, neuroimaging
might help reveal whether the unusual binding is functional or
structural. For example, if it is functional, we should expect to
ﬁnd increased connectivity in functional connectivity analyses on
fMRI data.
The above considerations raise the question of why only a small
fraction of brain injury patients acquire synesthesia-like experi-
ences. One possible answer is that individual differences originate
in variance in the degree of plasticity of the subject’s brain prior
to the incident. Research on brain injury in children has shown
that alterations in neurotransmission during the critical period
when a brain region is most plastic can promote outgrowth of
abnormal neural connections (Giza and Prins, 2006). Since it is
likely that there are signiﬁcant individual differences in the plastic-
ity of the mature brain, it is possible that some subjects are more
susceptible to the formation of new neural connections than oth-
ers. Individual differences are no doubt also grounded in variance
in the location of the injury. Synesthesia-like experiences may be
much more likely to develop if sensory regions or neural areas
implicated in mental imagery are affected.
Given the broad range of conditions that can trigger acquired
synesthesia it is unlikely that there is a single mechanism underly-
ing all cases. Some cases appear to be quite similar in persistence
and phenomenology to well-known forms of developmental
synesthesia and are likely to share a neurological basis with some
of these varieties of synesthesia. For example, autistic savant
Daniel Tammet describes in his book Born on a Blue Day that
he acquired synesthesia after childhood seizures. Though his
grapheme-color synesthesia appears unusually rich, it may have
neurological underpinnings akin to more typical developmental
forms. Other forms of acquired synesthesia appear to be tran-
sient and may well be a more direct product of excitatory neural
activity, similar in many respects to synesthetic experience occur-
ring under the inﬂuence of hallucinogens (see below). An example
would be synesthesia experienced during occipital and temporal
lobe seizures, which can lead to brief experiences quite similar to
psychedelic experiences (Devinsky and Luciano, 1991; Cytowic,
1997; Sacks, 2012). Some forms of acquired synesthesia could be
undergird by a different mechanism not typically found after drug
intoxication or aberrant neural development. In cases in which
synesthesia and savant syndrome are acquired in the same inci-
dent, the two conditions may well be triggered in similar ways.
This could be the case for Tammet, who reports having synes-
thesia matching not only digits but also the product of digits.
His synesthesia could possibly be an imagistic manifestation of
number processing in the parietal cortex. One observation that
supports this hypothesis is that the lack of increased activity in the
visual cortex in response to synesthetic tasks found in an imaging
study comparing brain activity in Tammet and controls (Bor et al.,
2007). Butmore researchneeds to be done to settle these questions.
In most cases of acquired synesthesia the research component has
taken place several years after the onset of the condition. If we
could perform the research (e.g., neuroimagining studies) closer
to the onset, we might be able to determine whether serotoner-
gic hyperactivity in sensory neurons is implicated in the sudden,
unusual binding of features.
DRUG-INDUCED SYNESTHESIA
Drug-induced synesthesia is a blending of perceptual or cog-
nitive streams that emerges in subjects under the inﬂuence of
psychedelic hallucinogens, psychoactive substances that alter per-
ception, mood, and a variety of cognitive processes. A myriad
of ﬁrst-person reports indicate that synesthesia occurs during
psychedelic intoxication. Some reports suggest an altered percep-
tion of the world that blends normally distinct senses. Reports
of colored music are particularly frequent (Shanon, 2002, 2003;
Sinke et al., 2012). In other cases external objects appear to the
perceiver as having an unusual wealth of colors, textures and
shapes that undergo rapid changes. Subjects report seeing melt-
ing windows, breathing walls and spiraling geometrical ﬁgures
crawling over the surfaces of objects. Reﬂecting on a DMT ses-
sion one subject, described by Cott and Rock (2008), reported
that “The room erupted in incredible neon colors, and dissolv-
ing into the most elaborate incredibly detailed fractal patterns
that I have ever seen.” The authors characterize this as a hallu-
cination, and it is admittedly difﬁcult to distinguish synesthesia
and hallucinations, particularly because some forms of synesthe-
sia probably are best characterized as hallucinations (Sagiv et al.,
2011). A crucial difference seems to be that hallucinations proper
do not have a phenomenally apparent inducer, whereas synesthe-
sia does. Another difference is that most forms of synesthesia are
experienced as endogenous images or representations (i.e., associ-
ator synesthesia, Dixon et al., 2004). Yet another difference is that
synesthetes know that the concurrent experience is not a veridical
perception, whereas hallucinations tend to evoke the experience
of the veridicality of the perception (Terhune and Cohen Kadosh,
2012).
It is by now fairly well established that two major classes of
psychedelic hallucinogens, the indoleamines (e.g., LSD and psilo-
cybin) and the phenethylamines (e.g., mescaline), are potent
partial agonists at serotonin 5-HT1A/2A/2C receptors, with 5-
HT2A receptor activation directly correlated with hallucinogenic
activity (Glennon, 1990; Vollenweider et al., 1998; Nichols, 2004;
Presti and Nichols, 2004; though see e.g., Previc, 2011 for a
different perspective). Though the mechanism of action varies
for different hallucinogens, it is believed that 5-HT2A receptor
activation of cortical neurons is responsible for mediating the
Frontiers in Human Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 657 | 4
“fnhum-07-00657” — 2013/10/17 — 21:48 — page 5 — #5
Brogaard Developmental, acquired and drug-induced synesthesia
signaling pattern and behavioral response to hallucinogens (Presti
and Nichols, 2004; González-Maeso et al., 2007). However, the
activation of the cortical serotonergic systemdoes not fully explain
the perceptual effects of psychedelic drugs, as not all 5-HT2A ago-
nists (or partial agonists) have an excitatory mechanism of action
and not all 5-HT2A agonists have psychedelic effects (e.g., methy-
sergide). So, this raises the question of what other factors need to
be present for drug-induced hallucinations to occur.
A promising suggestion for how the hallucinatory effects occur
is that hallucinogens activate layerV pyramidal neurons in the cor-
tex, which engage in gating functions in communication between
the cortex and subcortical brain regions (Barkai and Hasselmo,
1994). When a hallucinogen binds to the 5-HT2A receptor, this
gives rise to an excitatory response (Scruggs et al., 2003; Nichols,
2004). Recent research suggests that co-transmission of gluta-
mate and monoamines is a frequent occurrence in the central
nervous system (Trudeau, 2004; Ciranna, 2006). The 5-HT2A
receptors, speciﬁcally, have been found to increase glutamate
release (Ceglia et al., 2004; Torres-Escalante et al., 2004). There
is furthermore evidence suggesting that the hallucinogen psilo-
cybin targets a cortical receptor complex that forms when the
glutamate mGluR2 receptor interacts with the serotonin 5-HT2A
receptor (González-Maeso et al., 2008). Increased release of gluta-
mate in response to hallucinogen administration should enhance
cortical metabolic activity, a ﬁnding that has been conﬁrmed by
Vollenweider et al. (1997). Perceptual changes have been found to
correlate with increased metabolic activity in the frontomedial
and frontolateral cortices, anterior cingulate, and temporome-
dial cortex (Vollenweider et al., 1997). There is also some evidence
from EEG studies that activation of 5-HT2A receptors increases
the excitability of cortical sensory networks by modulating alpha
oscillations (8–12 Hz; Kometer et al., 2013). Brain waves in the
alpha frequency range have been shown to regulate the excitability
levels of cortical sensory networks through inhibition (Klimesch,
2011). The increased excitatory action of serotonin and gluta-
mate in sensory regions might explain why hallucinogens mimic
aspects of psychosis during intoxication (Aghajanian and Marek,
1999; Pralong et al., 2002; Nichols, 2004; González-Maeso et al.,
2008).
The view that the hallucinatory effects of hallucinogens are
primarily a result of enhanced neural activity may appear incon-
sistent with a recent fMRI study showing that psilocybin causes
decreased activity in the ACC/medial prefrontal cortex and a
signiﬁcant decrease in the positive coupling between the medial
prefrontal cortex and the posterior cingulate cortex, and that these
ﬁndings were correlated with subjective effects (Carhart-Harris
et al., 2012). As Lee and Roth (2012) point out, however, these
results are consistent with the observation that 5-HT2A receptors
are found on both layer V glutamatergic neurons and GABAer-
gic interneurons. Furthermore, there is also a direct activation
of GABAergic interneurons through the synapses of pyramidal
cells onto the interneurons (Markram et al., 2004). So, a large
excitatory response in a pyramidal neuron will lead to a large
inhibitory response in the interneuron. Lee and Roth (2012) pro-
pose that the effects of psilocybin could be due to both excitatory
(e.g., pyramidal) and inhibitory (e.g., GABAergic interneuronal)
neuronal circuits and that it may be the effects on the inhibitory
neuronal circuits that gave rise to the measured BOLD response
(see Figure 1).
To my knowledge, no model of how hallucinogens trigger
synesthesia has yet been proposed. One natural proposal would be
that the mechanisms in developmental and drug-induced synes-
thesia are similar. There is, however, some reason to doubt this
suggestion. The phenomenological differences between devel-
opmental and drug-induced synesthesia are quite striking (see
Sinke et al., 2012 for a review). As experiences causally supervene
on neurological processes, experiences that are signiﬁcantly dif-
ferent in their phenomenology are bound to have signiﬁcantly
different neurological underpinnings. So, we should expect some
differences in the underlying mechanisms.
One tentative suggestion is that drug-induced synesthesia,
like hallucinations, originates in the hyperactivity of layer V
pyramidal cells resulting from the binding of hallucinogens to
5-HT2A receptors in the cells’ dendrites, which then increases
local glutamate levels. Layer V pyramidal cells bind multisensory
information through feedback loops that synchronize oscillatory
neural responses (Guillery and Harting, 2003). In the visual and
the auditory cortices layer V neurons form feedback loops with
local neurons as well as neurons in the thalamus and prefrontal
cortex. Projections to thalamus play a role in discriminating
among incoming information and integrating information from
different sensory channels, whereas projections to the prefrontal
cortex play a role in higher-order processes and the generation
of a conscious representation. In normal multisensory percep-
tion, low-level multisensory binding of incoming signals from
visual and auditory channels occurs spontaneously in the audi-
tory cortex via thalamocortical feedback loops, when the spatial
and temporal attributes of incoming signals match (Schroeder
FIGURE 1 | Psilocybin, which is inactive, is metabolized to the active
ingredient psilocin. Psilocin then triggers a 5-HT2A excitatory response in
layer V pyramidal neurons and an inhibitory response in GABAergic
interneurons. The inhibitory response produces a decreased BOLD
response. Adapted from Lee, H.-M. and Roth, B. L. (2012). Hallucinogen
actions on human brain revealed. PNAS 109, 6: 1820–1821.
http://www.pnas.org/content/109/6/1820.full
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and Foxe, 2005). Excessive excitatory activity in layer V pyra-
midal neurons, however, results in a destabilization of layer V
projections to the thalamus through GABAergic neuronal cir-
cuits (Kim and McCormick, 1998; Markram et al., 2004). This
has a number of consequences, such as decreased attentional
discrimination among incoming stimuli, allowing more infor-
mation to ﬂood the sensory cortices, a loss of stimulus-speciﬁc
inhibition, an resultant increase of random (or environmentally
under-constrained) activity in the thalamus, and a disruption of
low-level, spontaneous integration of multisensory stimuli on
the basis of actually matching spatial and temporal attributes.
The disruption of low-level integration mechanisms can result
in incongruent experiences, such as hearing an object hit the
ﬂoor prior to seeing it fall. Another result of this disruption of
low-level integration may be a coupling of stimuli that do not
belong together. A common synesthetic experience during hal-
lucinogen intoxication is colored, geometrical grids, matrices or
fractals induced by music (see Sinke et al., 2012 for a review).
These types of visual experience also frequently occur without
an inducer, probably as a result of random activity in the thala-
mus (Behrendt and Young, 2004; Sagiv et al., 2011). One possible
mechanism for drug-induced synesthesia, then, is that the brain
assumes that an experience that results fromoccipital processing of
random thalamic activity matches auditory stimuli, leading to an
unusual low-level binding in the auditory cortex (see Figure 2). As
a result of this aberrant binding, the two inputsmaybe experienced
as an inducer-concurrent pair, for example colored, geometrical
music.
The proposed mechanism leads to the testable prediction that
drug-induced synesthesia will not usually be systematic. In devel-
opmental cases sound-color synesthesia is systematic in the sense
that very speciﬁc sounds normally trigger very speciﬁc colors.
Given the aberrant binding proposed, however, it appears that
drug-induced sound-color synesthesia will not tend to be system-
atic because random activity will be paired with available auditory
information. So, we should expect that the same sound may have
many different colors and shapes.
There are only few reports of drug-induced synesthesia that
endures post-exposure, though there is evidence that other prac-
tices that can induce altered states of consciousness, such as
meditation and posthypnotic suggestion, frequently cause endur-
ing synesthesia (Walsh, 2005; Cohen Kadosh et al., 2009). The
suggested mechanism may help explain why drug-induced synes-
thesia is seldom persistent over time. The hypothesis proposed
is that occipitally processed random activity is coupled with
available auditory information during drug-induction. The ran-
dom activity does not persist in the same magnitude after
drug exposure, which may explain why the synesthetic expe-
riences and hallucinations tend to subside. But what further
decreases the chance that the synesthesia persists would be the
lack of a one-one mapping or even a many-one mapping from
inducer to concurrent, which we might expect will make the
unusual synesthetic binding less likely to be retained as a neural
connection.
The proposed mechanism of hyperexcitability followed by dis-
ruption may appear to be inconsistent with a related ﬁnding for
FIGURE 2 | Psilocybin, which is inactive, is metabolized to the
active ingredient psilocin. Psilocin then triggers a 5-HT2A excitability
response in layer V pyramidal neurons and an inhibitory response in
GABAergic interneurons. This leads to thalamic destabilization, which
triggers random thalamic activity. The occipitally processed random
activity is paired with available auditory information in layer V
pyramidal neurons, which yields synesthetic experience. Adapted from
Figure 1.
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developmental synesthesia. It is believed that enhanced cortical
excitability at an early developmental stage might contribute to
atypical grapheme-color binding, even though it does not appear
to be a direct cause of synesthesia at later stages (Asher et al.,
2009; Tomson et al., 2011). A recent study reported data that
were consistent with the idea that at later stages the hyperex-
citability can hinder synesthesia by producing excess noise in
the visual cortex and thereby reducing conscious awareness of
the atypical binding of features (Terhune et al., 2011). However,
I think that this suggestion can be reconciled with the pro-
posed mechanism for drug-induced synesthesia. It is plausible
that hyperexcitability may no longer play a functional role at
later stages of developmental synesthesia (Terhune et al., 2011).
Hallucinogenic serotonin agonists, however, appear to intro-
duce a signiﬁcant amount of hyperexcitability that can offset
normal binding by disrupting low-level integration mechanisms.
It is possible that some varieties of developmental synesthesia
form in early childhood in a way similar to the way drug-
induced synesthesia is here hypothesized to form temporarily
later in life, but there would be certain differences: develop-
mental synesthesia is systematic so if synesthesia develops in
childhood as a result of a disruption of low-level integration,
it is not a result of random activity in the thalamus. Fur-
thermore, the presence of the hyperexcitability during brain
development must somehow make it more likely that the unusual
binding persists over time than when the hyperexcitability is
drug-induced.
A version of the proposed model also appears consistent with
the ﬁndings of Cohen Kadosh et al. (2009). The team induced
strong projector grapheme-color synesthesia using posthypnotic
suggestion in a group of highly suggestible college students. In
most cases the synesthesia was found to endure and to display
the phenomenal characteristics of developmental grapheme-color
synesthesia. Cohen Kadosh et al. (2009) provide evidence suggest-
ing that the induced synesthesia resulted from posthypnotically
triggered disinhibited feedback. However, their results seem
equally consistent with a model that proposes disruption of low-
level integration. One shortcoming of both mechanistic proposals
for synesthesia induced post hypnosis is that they do not explain
why the condition tends to enduremuch longer thandrug-induced
synesthesia.
A further interesting question is whether the above model
could be adapted to explain acquired synesthesia in which necro-
sis leads to neurotransmitter ﬂooding and elevated local serotonin
levels. Though we do not have enough data on acquired synes-
thesia to make any ﬁrm conclusions at this point, it remains
a possibility that some forms of developmental synesthesia are
acquired in childhood in the same way as the persistent cases
of acquired synesthesia, whereas temporarily acquired synes-
thesia is mechanistically akin to drug-induced synesthesia. If
this is correct, then we should expect drug-induced synesthesia
and temporarily acquired synesthesia to both lack systematic-
ity, as they would result from pairing features with random
information. We should furthermore expect persisting forms
of acquired synesthesia to have the same patterns of perma-
nence and systematicity as at least some forms of developmental
synesthesia.
DEVELOPMENTAL SYNESTHESIA IN AUTISTIC AND
NON-AUTISTIC INDIVIDUALS
Though it is difﬁcult to say whether alterations in the serotonergic
system play a role in the development of the most common forms
developmental synesthesia, such as week-color and grapheme-
color, developmental synesthesia seen in autism spectrumdisorder
is plausibly triggered by unilateral changes in the serotonergic sys-
tem (Milner, 1973; Chugani et al., 1997; DeLong, 1999). There is
not yet any solid evidence that autism and synesthesia are mech-
anistically related but there appears to be a statistical correlation
as well as a possible genetic connection between the two condi-
tions: synesthesia as well as sensory and perceptual abnormalities,
such as hyper-responsiveness to sensory stimulation, are often
reported as signiﬁcant symptoms in autism-spectrum disorders
(Ornitz et al., 1978; Grandin, 1995; Kemner et al., 1995; Harri-
son and Hare, 2004; Asher et al., 2009; Baron-Cohen et al., 2009).
Cytowic (1989) states that 15 percent of people with autism expe-
rience synesthesia, which would be signiﬁcant compared to the
4.4 percent of the general population (Simner et al., 2006). How-
ever, a systematic population study of the correlation between
autism and synesthesia has not yet been completed. About 10
percent of individuals with autism also have savant syndrome,
and all three conditions have frequently been reported to occur
together (Baron-Cohen et al., 2007; Bor et al., 2007; Rothen et al.,
2012). Recently, a genetic link between synesthesia and autism was
suggested (Asher et al., 2009). Despite the lack of solid evidence
for a mechanistic connection between autism and synesthesia,
the existing statistical and genetic correlations give us reason to
explore how serotonin may be related to synesthesia in autis-
tic individuals. I will look at the evidence for the serotonin
hypothesis for autism and then propose some testable predic-
tions about how serotonin may give rise to synesthesia in autistic
individuals.
The evidence that serotonin plays a crucial role in autism is
overwhelming. About 30 percent of autistic individuals have a 25
to 70 percent increase in blood levels of serotonin, also known
as hyperserotonemia (Schain and Freedman, 1961; Chugani et al.,
1997, 1999; Veenstra-VanderWeele et al., 2012). Hyperserotone-
mia has also been found to a similar degree in ﬁrst-degree healthy
relatives (Leboyer et al., 1999). As serotonin cannot normally cross
the blood-brain barrier in adults, high blood levels of serotonin
are not necessarily a good indicator of high extracellular serotonin
in the brain. High blood levels of serotonin, however, may indi-
cate brain levels of serotonin in young children, as the blood-brain
barrier is not fully developed until the age of two. Higher rates of
autism have also been found in children exposed in utero to drugs
that increase 5-HT levels, such as cocaine (Kramer et al., 1994).
The high levels of serotonin in young children can negatively affect
the development of serotonin neurons through negative feedback.
As serotonin neurons develop and the extracellular levels of the
neurotransmitter increase, growth of serotonin neurons is nor-
mally curtailed through a negative feedback mechanism, leading
to a loss of serotonin terminals (DeLong, 1999; Whitaker-Azmitia,
2005). This decrease in serotonin terminal development has also
been found in animal studies administeringmonoamine oxidaseA
and B inhibitors or serotonin reuptake inhibitors during gestation
(Whitaker-Azmitia et al., 1994).
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Several PET imaging studies have suggested that autism may
be a lateralized syndrome, with decreased serotonin release from
raphe terminals in one hemisphere (typically the left) and ele-
vated serotonin release in the contralateral hemisphere (Chugani
et al., 1997, 1999; Chandana et al., 2005). Signiﬁcantly increased
language impairment was found in subjects with decreased sero-
tonin synthesis in the left hemisphere compared to individuals
with right-hemisphere abnormalities and those without cortical
asymmetry. Further evidence for the lateralization theory comes
from studies indicating functional improvement with selective
serotonin reuptake inhibitors (SSRIs), such ﬂuoxetine (DeLong,
1999). SSRIs block serotonin transporters, preventing extracel-
lular serotonin from being transported back into the cell. When
children with autism are treated with SSRIs, the symptoms they
share in common with individuals with major depressive disorder
and anxiety disorders drastically improve. The children’s range
of interests broaden, their perceptual experiences normalize, their
memory and cognitive functions improve and anxiety and phobias
become less prominent. Depleting brain serotonin in a tryptophan
depletion paradigm, on the other hand, results in a worsening
of the mood-related symptoms of autism as well as behav-
iors such as whirling, ﬂapping, rocking and pacing (McDougle
et al., 1996), though it does not affect the other symptoms of
autism.
One possible explanation of the asymmetry is that the early
serotonin depletion in the dominant left hemisphere leads to
overcompensation in the right hemisphere. It has been reported
that a decrease in extracellular serotonin over time may lead
to an excessive spread of thalamocortical axon branches, result-
ing in lower information-transmission and structural changes in
affected cortical regions aswell as underdeveloped long-range con-
nections between different brain areas (DeLong, 1999; Mueller
et al., 2013). When the decrease in serotonin is left-lateralized,
this leads to a general hypoexcitability of the left hemisphere
and a wider right parietooccipital region compared to individuals
with mental retardation or miscellaneous neurological disorders
(Hier et al., 1979). The reversal of the asymmetry may be the
result of initial right-hemisphere dominance, as indicated by
a higher incidence of left-handedness and improved language
skills in autistic individuals with decreased serotonin synthesis
in the right hemisphere (Chandana et al., 2005). These results
may explain why savant syndrome occurs in ten percent of autis-
tic individuals. The leading hypothesis is that savant syndrome
is caused by a lesion or birth defect in one hemisphere that
results in overcompensation by the other hemisphere (Pesenti
et al., 2001; Snyder et al., 2003; Young et al., 2004; Treffert, 2009;
Loui et al., 2011).
A hemispheric effect does not provide clear evidence for a role
of serotonin in synesthesia, as not all individuals with autism
have synesthesia. But the expected high frequency of synesthesia
in autistic individuals together with the lateralization hypoth-
esis point to the possibility that increased extracellular levels
of serotonin in the autistic brain may be a causal inﬂuence
on the genesis of synesthesia in individuals with this disor-
der. There appears to be two ways in which serotonin could
be implicated in synesthesia in autistic individuals. One possi-
bility is that the high serotonin levels in very young children
with autism sometimes trigger altered multisensory processing.
Another possibility is that compensatory high serotonin levels in
the contralesional hemisphere sometimes cause unusual feature
binding. If the former hypothesis is correct, then we should expect
to ﬁnd evidence of synesthesia in autistic individuals at a very
young age.
There are multiple ways that elevated serotonin levels may lead
to synesthesia in autistic individuals. If the onset of synesthesia in
autism occurs at an early age, it could be the result of serotonin-
triggered hyperactivity in glutamatergic neurons in layer V and
resulting destabilization of thalamic connections. If this hypoth-
esis is correct for synesthesia in autistic individuals, then we
should expect that the synesthetic connections can persist only
in the form of tight memory connections after the subsequent
loss of serotonin-terminals in large areas of the brain. Accord-
ingly, on the assumption that projector synesthesia is not normally
mnemonic, we should not expect to ﬁnd a signiﬁcant number
of projector synesthetes among autistic individuals. Another way
synesthetic connections could form would be through the early
excessive formation of neural pathways. Persisting synesthesia in
this case would require that the early formed structural connec-
tions could survive the extensive pruning that appears to take place
when serotonin-terminals are lost. If the onset of the synesthesia
does not occur at an early age, structural or functional synes-
thetic connections could still form in the spared right-hemisphere
regions that are also believed to be responsible for the savant
skills founds in 10 percent of autistic individuals. Structural
connectivity mechanisms have been proposed for standard cases
of grapheme-color synesthesia, suggesting unusual connectivity
between the color area and the fusiformgyrus (Ramachandran and
Hubbard, 2001a,b; Hubbard et al., 2005). Enhanced anatomical
connectivity near the fusiform gyrus conﬁrming this hypoth-
esis has been reported for grapheme-color synesthesia (Rouw
and Scholte, 2007; Jancke et al., 2009; Hanggi et al., 2011) and
sound-color synesthesia (Zamm et al., 2013). Whether a struc-
tural connectivity mechanism also underlies synesthesia in autism
could fairly easily be tested by using a DTI paradigm to look
at whether there are similar patterns of localized hyper-cortical-
connectivity in autistic individuals with synesthesia. If the onset of
the synesthesia does not occur at an early age, there is also the pos-
sibility that it is the result of impaired higher-order multisensory
integration associated with decreased functional and structural
connectivity (Mueller et al., 2013). This would make developmen-
tal synesthesia in autism very different from other cases, which
appear to be a result of increased structural or functional con-
nectivity. There is, however, a fairly strong reason against this
mechanism as explanatory of synesthesia in autistic individuals.
Impaired multisensory integration in autism amounts to a fail-
ure to associate two high-level sensory input that neurotypical
individuals would associate (Mueller et al., 2013), not a persistent
success in associating two input that neurotypical individuals do
not associate.
Whether a hyperactive serotonergic system can contribute to
developmental synesthesia innon-autistic individuals is unknown.
As autism is partly deﬁned by sensory processing deﬁcits, the
emergence of synesthesia in autism could be a consequence of
other sensory alterations and originate from a unique set of
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mechanisms distinct from those present in other cases of develop-
mental synesthesia. But some data points indicate that serotonin
may be mechanistically involved in producing synesthetic expe-
rience through altered functional connectivity. As Brang and
Ramachandran (2007) observed, there is some reported phar-
macological evidence suggesting that developmental synesthesia
in non-autistic individuals could sometimes be a serotonergic
condition. Pharmacological evidence for the serotonin hypoth-
esis was also reported by Cytowic (1989). He describes a patient
with life-long synesthesia who developed epilepsy as an adult and
subsequently experienced less vivid synesthetic experiences when
treated with the anti-epileptic drug Tegretol (carbamazepine),
which is known to increase extracellular levels of serotonin
(Cytowic, 1989, p. 174). The reports from Cytowic (1989) and
Brang and Ramachandran (2007) may seem to provide evidence
against serotonin triggering synesthesia via excitatory activity,
as the increased serotonin levels apparently inhibited synesthe-
sia. However, both ﬂuoxetine and carbamazepine have been
shown to signiﬁcantly increase GABA and reduce glutamate lev-
els, which would block the excitatory effects of serotonin in
cortical areas (Kamal, 2010). So, these data suggest that sero-
tonin may be functionally involved in generating synesthetic
experience either through a disinhibited feedback mechanism
or by making unusual structural binding available for con-
scious processing. The pharmacological evidence thus lends some
support to a disinhibited feedback mechanism, which suggests
that synesthesia is not a result of altered structural connec-
tivity but arises from altered functional feedback connections.
This type of mechanism has received prior support from psy-
chophysical and neuromagining studies of non-autistic synes-
thetes (Grossenbacher and Lovelace, 2001; Dixon et al., 2006;
Esterman et al., 2006; Neufeld et al., 2012). A recent imaging
study of 14 auditory-visual non-autistic synesthetes, for exam-
ple, found increased functional connectivity of the left inferior
parietal cortex with the left primary auditory and right primary
visual cortex (Neufeld et al., 2012), suggesting that the aberrant
synesthetic binding takes place in parietal cortex. There is also
suggestive evidence of mixed mechanisms. For example, some
forms of grapheme-color synesthesia appear to involve enhanced
visual memory associations with hyper-reinstantiation in the
visual cortex (see Brogaard, 2013 and Brogaard et al., 2013 for
reviews).
Drawingon evidence that the 5-HT2A receptormaybe involved
in generating synesthetic experience, Brang and Ramachandran
(2007) suggest that synesthesia might occur from overexpression
of the 5-HT2A receptor gene on chromosome13. Awhole-genome
linkage scan and a family-linkage analysis in a sample of 43 mul-
tiplex families with auditory-visual synesthesia did not conﬁrm
this hypothesis (Asher et al., 2009). Instead the study suggested
that synesthesia may be traceable to a region on chromosome 2
(2q24.1) that has been implicated in autism (Newbury et al., 2009),
indicating that there may be genetic link between developmental
synesthesia and autism.
Other evidence gives some credit to the hypothesis that synes-
thesia in non-autistic individuals could be related in terms of
brain structure to autism and savant syndrome and hence that
a particular brain structure may underlie all of these conditions.
Population studies suggest that there may be a higher inci-
dence of synesthesia among people with creative talent (Domino,
1989; Mulvenna and Walsh, 2005; Simner et al., 2006; Rothen
and Meier, 2010). Conversely, some synesthetes appear to have
greater cognitive and memory capacities speciﬁc to the con-
current of the individual’s synesthesia compared to the general
population (Yaro and Ward, 2007; Ward et al., 2008; Banissy
et al., 2009; Rothen et al., 2012). The possible association between
synesthesia and cognitive talent might suggest that synesthetes
without autism have serotonin-induced hyperconnected neural
networks without the down-regulated neural regions found in
people with autism. Recent neuroimaging studies further point
to enhanced functional connectivity or increased gray matter
density in synesthesia. A recent functional MRI study found
increased intrinsic network connectivity in 12 grapheme-color
synesthetes that reﬂected the strength of their synesthetic expe-
riences (Dovern et al., 2012). Wiess and Fink (2009) further
reported greater gray matter volume in the left intraparietal sulcus
and right fusiform gyrus in 18 synesthetes compared to 18 con-
trols. Several DTI studies have conﬁrmed increased white matter
connections in the superior parietal cortex, right inferior tem-
poral cortex and frontal regions in grapheme-color synesthesia
(Rouw and Scholte, 2007; Jancke et al., 2009, though at more
liberal thresholds; Hanggi et al., 2011) and sound-color synesthe-
sia (Zamm et al., 2013). Although these lines of evidence do not
provide evidence of a causal connection among developmental
synesthesia, autism and savant syndrome, results are sugges-
tive that local hyperconnectivity is a common feature of these
conditions.
However, we do not yet have enough data to draw any ﬁrm
conclusions about the role of serotonin in developmental synes-
thesia in non-autistic individuals or the connection between
developmental synesthesia and autism. More systematic popu-
lation studies as well as whole-genome linkage scans and family
linkage analyses may be able to shed more light on this connec-
tion. The extent to which serotonin is mechanistically involved
in developmental synesthesia could be tested more systematically
in pharmacological studies using drugs known to inhibit 5-HT2A
receptors, such as SSRIs (Brang and Ramachandran, 2007), and
serotonin-agonists, such as cocaine, that are only reported to
cause hallucinations with excessive use. If serotonin is functionally
implicated in synesthesia, we should expect 5-HT2A inhibitors to
block or reduce synesthesia and serotonin-agonists to augment
the experiences. A negative result would rule out that serotonin is
functionally involved in synesthesia but would leave open the pos-
sibility that the neurotransmitter is involved in the onset of devel-
opmental synesthesia by leading to an early change in structural
connectivity.
CONCLUSION
Theprimary aimhere has been todefend thehypothesis that synes-
thesia is at least sometimes a hyperserotonergic condition that
triggers synesthesia through excitatory neurotransmitter action.
The main evidence in favor of this hypothesis can be summarized
as follows:
First of all, brain injury that gives rise to acquired synesthesia
leads to necrosis and excessive release of serotonin and glutamate.
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Though this increase in excitatory neurotransmitter activity leads
to lower excitability in local areas throughnegative feedbackwithin
weeks, decreased activity in affected neural regions could lead to
a disinhibitory enhancement of neural activity and connectivity
in unaffected cortical regions. Alternatively, the early increase in
serotonin levels could lead to the formation of unusual feature
binding.
Secondly, administration of certain hallucinogenic serotonin
agonists (e.g., psilocybin) induces synesthesia. The mecha-
nism underlying drug-induced synesthesia plausibly involves
serotonergic excitatory activity in layer V pyramidal neurons
implicated in multisensory binding.
Thirdly, serotonin synthesis is typically increased unilater-
ally in individuals with autism, about 15 percent of which are
believed to experience synesthesia compared to about 4 per-
cent population-wide. In terms of a potential mechanism, one
possibility is that serotonin causes aberrant structural bind-
ing in the spared neural regions that are also responsible
for the savant skills found in 10 percent of autistic indivi-
duals.
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